Bernice Aidoo, MD
Hospitalist · Takoma Park, MDNPI 1750540837
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 45 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Johnson & Johnson at 30.2% of the total. Reporting peaked in 2023 at $193 and has fallen 68.9% since, to $60 in 2025. Among hospitalist clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 45 payments — averaging $19.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$269
- Pfizer$116
- Merck$87
- Smith+Nephew$78
- Novo Nordisk$71
- UCB, Inc.$58
- plus $211 from 7 others
What the payments were for
- Food & beverage$889100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 16 | $269 |
| Pfizer | 6 | $116 |
| Merck | 4 | $87 |
| Smith+Nephew | 4 | $78 |
| Novo Nordisk | 3 | $71 |
| UCB, Inc. | 2 | $58 |
| Fisher & Paykel Healthcare Inc | 2 | $49 |
| Gilead | 2 | $38 |
| Mylan Specialty L.p. | 2 | $38 |
| AstraZeneca | 1 | $34 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Vapotherm Inc | 1 | $19 |
| Melinta Therapeutics, LLC | 1 | $14 |
How this compares
$889 in reported general payments places this provider in the 90th percentile of 414 hospitalist providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 23 | $208 |
| Atorvastatin Calcium | 20 | $183 |
| Famotidine | 15 | $112 |
| CefuroximeCefuroxime Axetil | 18 | $89 |
| Furosemide | 12 | $71 |
| Amlodipine Besylate | 17 | $67 |
| Levofloxacin | 13 | $42 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Takoma Park
- Mahrukh RiazTakoma Park$2K
- Eric RitterBaltimore$94K
- Francoise MarvelBaltimore$63K
- Sarojini QasbaBethesda$53K
- Anweshan SamantaBaltimore$24K
- Turja ChakrabartiBaltimore$6K
- Ajay HoodaBaltimore$5K
- Arshia SoleimaniGlen Burnie$5K
- Manu MysoreBaltimore$4K
- Nilesh PatelBaltimore$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.